Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Axatilimab Produces Significant Response in Patients with Fatal Post-Transplant Complication
July 25th 2023Co-developers Incyte and Syndax will submit a biologics license application to the FDA at the end of 2023 based on the results of a phase 2 trial among adult and pediatric patients with chronic graft-versus-host disease.
Read More
Confirmatory PAPILLON Study Supports Amivantamab-vmjw For Patients with Severe Lung Cancer Mutation
July 19th 2023The 5-year survival rate for patients with exon 20 insertion EFGR mutation is 8% in the frontline setting, worse than the survival rate of the 2 most common types of EGFR mutations in patients with advanced or metastatic non-small cell lung cancer.
Read More
Expert Panel Discusses Advocacy, Education for Patients With Myeloproliferative Neoplasms
July 14th 2023Despite a slew of barriers with patient management, pharmacists have the training and resources to advocate for better patient care and help patients with hematologic myeloproliferative neoplasms advocate for themselves.
Read More